Your browser doesn't support javascript.
loading
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.
Jacobs, Tom G; Mumbiro, Vivian; Chitsamatanga, Moses; Namuziya, Natasha; Passanduca, Alfeu; Domínguez-Rodríguez, Sara; Tagarro, Alfredo; Nathoo, Kusum J; Nduna, Bwendo; Ballesteros, Alvaro; Madrid, Lola; Mujuru, Hilda A; Chabala, Chishala; Buck, W Chris; Rojo, Pablo; Burger, David M; Moraleda, Cinta; Colbers, Angela.
Afiliación
  • Jacobs TG; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Chitsamatanga M; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Namuziya N; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Passanduca A; Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
  • Domínguez-Rodríguez S; Pediatric Unit for Research and Clinical Trials (UPIC), Hospital 12 de Octubre Health Research Institute (i+12), Biomedical Foundation of Hospital Universitario 12 de Octubre (FIB-H12O), Madrid, Spain.
  • Tagarro A; Pediatric Unit for Research and Clinical Trials (UPIC), Hospital 12 de Octubre Health Research Institute (i+12), Biomedical Foundation of Hospital Universitario 12 de Octubre (FIB-H12O), Madrid, Spain.
  • Nathoo KJ; Pediatric Service. Infanta Sofia University Hospital, Servicio Madrileño de Salud (SERMAS), Madrid, Spain.
  • Nduna B; Universidad Europea de Madrid.
  • Ballesteros A; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Madrid L; Arthur Davidson Children's Hospital, Ndola, Zambia.
  • Mujuru HA; Pediatric Unit for Research and Clinical Trials (UPIC), Hospital 12 de Octubre Health Research Institute (i+12), Biomedical Foundation of Hospital Universitario 12 de Octubre (FIB-H12O), Madrid, Spain.
  • Chabala C; Pediatric Unit for Research and Clinical Trials (UPIC), Hospital 12 de Octubre Health Research Institute (i+12), Biomedical Foundation of Hospital Universitario 12 de Octubre (FIB-H12O), Madrid, Spain.
  • Buck WC; London School of Hygiene and Tropical Medicine (LMC), London UK.
  • Rojo P; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Burger DM; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Moraleda C; University of Zambia, School of Medicine, Lusaka, Zambia.
  • Colbers A; Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
J Acquir Immune Defic Syndr ; 93(1): 42-46, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36724434
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH Tipo de estudio: Guideline Límite: Child / Female / Humans / Infant / Male Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH Tipo de estudio: Guideline Límite: Child / Female / Humans / Infant / Male Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos